Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 4Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Polycystic Ovary Syndrome 2Overweight 1Metabolic Syndrome 1Insulin Resistance 1Infertility 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × drospirenone × Clear all
NCT01519401 2020-07-24

Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Catholic University of the Sacred Heart

Phase NA Completed
50 enrolled

Polycystic Ovary Syndrome

NCT00442689 2014-06-06

Metabolic Syndrome in PCOS: Precursors and Interventions

Northwestern University

Phase NA Completed
97 enrolled 13 charts

Infertility, Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡